October 21, 2009
Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis™ HIV Program...

June 10, 2009
Argos Therapeutics Publishes Research on the Immunosuppressive Properties of HIV

 
   
   
 

Upcoming Events
Canadian Trial Network

18th Annual Canadian Conference on HIV/AIDS Research

 
   
   
main image